Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

Neuron

Volumn 73, Issue 4, 2012, Pages 685-697

  De Calignon, Alix ^a,b   Polydoro, Manuela ^a   Suárez Calvet, Marc ^a,c   William, Christopher ^a   Adamowicz, David H ^a   Kopeikina, Kathy J ^a,d   Pitstick, Rose ^e   Sahara, Naruhiko ^f   Ashe, Karen H ^g   Carlson, George A ^e   Spires Jones, Tara L ^a   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MCLAUGHLIN RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSOCIATION CORTEX; CELL LOSS; CELL POPULATION; CELL TRANSPORT; CINGULATE GYRUS; CONTROLLED STUDY; DEAFFERENTATION; DENTATE GYRUS; DISEASE COURSE; DISEASE MODEL; ENTORHINAL CORTEX; GENE EXPRESSION; GENE OVEREXPRESSION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HUMAN; HUMAN TISSUE; LIMBIC CORTEX; MOUSE; NERVE CELL; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN TRANSPORT; SYNAPSE; TRANSGENE; TRANSGENIC MOUSE;

AGE FACTORS; ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENTORHINAL CORTEX; EPITOPES; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HIPPOCAMPUS; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; NEURONS; RNA, MESSENGER; SERINE; TAU PROTEINS; TAUOPATHIES;

EID: 84857275902     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2011.11.033     Document Type: Article

References (51)

1. Ballatore C., Lee V.M., Trojanowski J.Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 2007, 8:663-672.
2. Barten D.M., Cadelina G.W., Hoque N., DeCarr L.B., Guss V.L., Yang L., Sankaranarayanan S., Wes P.D., Flynn M.E., Meredith J.E., et al. Tau transgenic mice as models for cerebrospinal fluid tau biomarkers. J. Alzheimers Dis. 2011, 24(Suppl 2):127-141.
3. Blennow K., Wallin A., Agren H., Spenger C., Siegfried J., Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?. Mol. Chem. Neuropathol. 1995, 26:231-245.
4. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
5. Canto C.B., Wouterlood F.G., Witter M.P. What does the anatomical organization of the entorhinal cortex tell us?. Neural Plast. 2008, 2008:381243.
6. Chin S.S., Goldman J.E. Glial inclusions in CNS degenerative diseases. J. Neuropathol. Exp. Neurol. 1996, 55:499-508.
7. Clavaguera F., Bolmont T., Crowther R.A., Abramowski D., Frank S., Probst A., Fraser G., Stalder A.K., Beibel M., Staufenbiel M., et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 2009, 11:909-913.
8. de Calignon A., Fox L.M., Pitstick R., Carlson G.A., Bacskai B.J., Spires-Jones T.L., Hyman B.T. Caspase activation precedes and leads to tangles. Nature 2010, 464:1201-1204.
9. DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 1990, 27:457-464.
10. Delacourte A., David J.P., Sergeant N., Buée L., Wattez A., Vermersch P., Ghozali F., Fallet-Bianco C., Pasquier F., Lebert F., et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999, 52:1158-1165.
11. Franklin K., Paxinos G. The Mouse Brain in Stereotaxic Coordinates, Third Edition 2007, Academic Press, San Diego, CA.
12. Frost B., Jacks R.L., Diamond M.I. Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 2009, 284:12845-12852.
13. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol. Acad. Sci. Hung. 1971, 19:1-8.
14. Geinisman Y. Loss of axosomatic synapses in the dentate gyrus of aged rats. Brain Res. 1979, 168:485-492.
15. Geinisman Y., Bondareff W., Dodge J.T. Partial deafferentation of neurons in the dentate gyrus of the senescent rat. Brain Res. 1977, 134:541-545.
16. Gómez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 1996, 16:4491-4500.
17. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 1992, 89:5547-5551.
18. Harris J.A., Devidze N., Verret L., Ho K., Halabisky B., Thwin M.T., Kim D., Hamto P., Lo I., Yu G.Q., et al. Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron 2010, 68:428-441.
19. Hasegawa M., Arai T., Akiyama H., Nonaka T., Mori H., Hashimoto T., Yamazaki M., Oyanagi K. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 2007, 130:1386-1394.
20. Hjorth-Simonsen A., Jeune B. Origin and termination of the hippocampal perforant path in the rat studied by silver impregnation. J. Comp. Neurol. 1972, 144:215-232.
21. Hyman B.T., Trojanowski J.Q. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J. Neuropathol. Exp. Neurol. 1997, 56:1095-1097.
22. Hyman B.T., Van Hoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984, 225:1168-1170.
23. Hyman B.T., Kromer L.J., Van Hoesen G.W. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease. Ann. Neurol. 1987, 21:259-267.
24. Hyman B.T., Kromer L.J., Van Hoesen G.W. A direct demonstration of the perforant pathway terminal zone in Alzheimer's disease using the monoclonal antibody Alz-50. Brain Res. 1988, 450:392-397.
25. Hyman B.T., Van Hoesen G.W., Damasio A.R. Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology 1990, 40:1721-1730.
26. Hyman B.T., Gomez-Isla T., Irizarry M.C. Stereology: a practical primer for neuropathology. J. Neuropathol. Exp. Neurol. 1998, 57:305-310.
27. Iliev A.I., Ganesan S., Bunt G., Wouters F.S. Removal of pattern-breaking sequences in microtubule binding repeats produces instantaneous tau aggregation and toxicity. J. Biol. Chem. 2006, 281:37195-37204.
28. Irizarry M.C., McNamara M., Fedorchak K., Hsiao K., Hyman B.T. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 1997, 56:965-973.
29. Johnson G.V., Seubert P., Cox T.M., Motter R., Brown J.P., Galasko D. The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J. Neurochem. 1997, 68:430-433.
30. Koffie R.M., Meyer-Luehmann M., Hashimoto T., Adams K.W., Mielke M.L., Garcia-Alloza M., Micheva K.D., Smith S.J., Kim M.L., Lee V.M., et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc. Natl. Acad. Sci. USA 2009, 106:4012-4017.
31. Micheva K.D., Smith S.J. Array tomography: a new tool for imaging the molecular architecture and ultrastructure of neural circuits. Neuron 2007, 55:25-36.
32. Mocanu M.M., Nissen A., Eckermann K., Khlistunova I., Biernat J., Drexler D., Petrova O., Schönig K., Bujard H., Mandelkow E., et al. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J. Neurosci. 2008, 28:737-748.
33. Nakano I., Iwatsubo T., Otsuka N., Kamei M., Matsumura K., Mannen T. Paired helical filaments in astrocytes: electron microscopy and immunohistochemistry in a case of atypical Alzheimer's disease. Acta Neuropathol. 1992, 83:228-232.
34. Nishimura M., Tomimoto H., Suenaga T., Namba Y., Ikeda K., Akiguchi I., Kimura J. Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain. Am. J. Pathol. 1995, 146:1052-1058.
35. Papasozomenos S.C. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications. Lab. Invest. 1989, 60:123-137.
36. Papasozomenos S.C. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments. Lab. Invest. 1989, 60:375-389.
37. Price S.R., De Marco Garcia N.V., Ranscht B., Jessell T.M. Regulation of motor neuron pool sorting by differential expression of type II cadherins. Cell 2002, 109:205-216.
38. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McGowan E., et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309:476-481.
39. Schaeren-Wiemers N., Gerfin-Moser A. A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry 1993, 100:431-440.
40. Scheff S.W., Price D.A. Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus. J. Alzheimers Dis. 2006, 9(3, Suppl):101-115.
41. Steward O. Topographic organization of the projections from the entorhinal area to the hippocampal formation of the rat. J. Comp. Neurol. 1976, 167:285-314.
42. Sun A., Nguyen X.V., Bing G. Comparative analysis of an improved thioflavin-s stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J. Histochem. Cytochem. 2002, 50:463-472.
43. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30:572-580.
44. Tremblay M.A., Acker C.M., Davies P. Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg. J. Alzheimers Dis. 2010, 19:721-733.
45. Tucker K.L., Meyer M., Barde Y.A. Neurotrophins are required for nerve growth during development. Nat. Neurosci. 2001, 4:29-37.
46. van Groen T. Entorhinal cortex of the mouse: cytoarchitectonical organization. Hippocampus 2001, 11:397-407.
47. Van Hoesen G., Pandya D.N. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. I. Temporal lobe afferents. Brain Res. 1975, 95:1-24.
48. Witter M.P. The perforant path: projections from the entorhinal cortex to the dentate gyrus. Prog. Brain Res. 2007, 163:43-61.
49. Witter M.P., Griffioen A.W., Jorritsma-Byham B., Krijnen J.L. Entorhinal projections to the hippocampal CA1 region in the rat: an underestimated pathway. Neurosci. Lett. 1988, 85:193-198.
50. Yasuda M., Mayford M.R. CaMKII activation in the entorhinal cortex disrupts previously encoded spatial memory. Neuron 2006, 50:309-318.
51. Zhao L., Ma Q.L., Calon F., Harris-White M.E., Yang F., Lim G.P., Morihara T., Ubeda O.J., Ambegaokar S., Hansen J.E., et al. Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat. Neurosci. 2006, 9:234-242.